Bladder cancer. Human leukocyte antigen II, interleukin-6, and interleukin-6 receptor expression determined by the polymerase chain reaction
Authors:
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- RAS enzyme-linked immunoblot assay discriminates p21 species: A technique to dissect gene family expressionAnalytical Biochemistry, 1989
- Allelic Loss in Colorectal CarcinomaJAMA, 1989
- Prediction of Relapse or Survival in Patients with Node-Negative Breast Cancer by DNA Flow CytometryNew England Journal of Medicine, 1989
- Wound Macrophages Express TGF-α and Other Growth Factors in Vivo: Analysis by mRNA PhenotypingScience, 1988
- Diagnosis of chronic myeloid and acute lymphocytic leukemias by detection of leukemia-specific mRNA sequences amplified in vitro.Proceedings of the National Academy of Sciences, 1988
- Relative worth of estrogen or progesterone receptor and pathologic characteristics of differentiation as indicators of prognosis in node negative breast cancer patients: findings from National Surgical Adjuvant Breast and Bowel Project Protocol B-06.Journal of Clinical Oncology, 1988
- The Predictive Value of Flow Cytometric Information in the Clinical Management of Stage O (Ta) Bladder CancerJournal of Urology, 1988
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/neuOncogeneScience, 1987
- [21] Specific synthesis of DNA in vitro via a polymerase-catalyzed chain reaction1987
- HLA-DR Antigen Expression in Primary Melanomas of the SkinJournal of Investigative Dermatology, 1984